How Long Does Percocet Stay in Your System?

Percocet stays in your system for 1 to 3 days in urine, up to 24 hours in blood, 1 to 4 days in saliva, and up to 90 days in hair follicle tests.

The detection window depends on the dose taken, frequency of use, individual metabolism, and the type of drug test administered.

Percocet contains two active ingredients: oxycodone (an opioid analgesic) and acetaminophen (a non-opioid pain reliever). Oxycodone has a half-life of approximately 3.2 hours, meaning the body eliminates half the drug roughly every 3 hours.

Whether you are managing a prescription or preparing for a drug screening, understanding how Percocet moves through your body helps you make informed decisions.

Key Takeaways

• Percocet contains oxycodone, a Schedule II opioid with a plasma half-life of approximately 3.2 hours. Complete elimination from the bloodstream requires 4 to 5 half-lives, totaling approximately 16 to 20 hours.
• The Substance Abuse and Mental Health Services Administration (SAMHSA) sets the standard immunoassay screening cutoff for opioids at 2,000 ng/mL, with confirmatory testing at 100 ng/mL specifically for oxycodone.
• Urine drug tests detect oxycodone for 1 to 3 days after the last dose, though chronic users may test positive for up to 4 days due to metabolite accumulation.
• According to the 2024 NSDUH, approximately 8.5 million Americans aged 12 or older reported past-year prescription opioid misuse, with oxycodone-containing products among the most frequently misused formulations.
• Standard 5-panel urine immunoassays may not detect oxycodone because they screen for morphine-derived opioids. An expanded opioid panel or specific oxycodone assay is required for reliable detection.

What Is Percocet?

Percocet is a brand-name prescription pain medication containing a fixed-dose combination of oxycodone hydrochloride and acetaminophen.

Oxycodone: The Opioid Component

Oxycodone is a semi-synthetic opioid analgesic derived from thebaine, an alkaloid found in the opium poppy. The DEA classifies oxycodone as a Schedule II controlled substance due to its high potential for misuse and physical dependence.

Oxycodone binds to mu-opioid receptors in the central nervous system, producing dose-dependent analgesia, euphoria, sedation, and respiratory depression. This mu-opioid receptor activation drives both the therapeutic pain relief and the misuse potential that characterize all oxycodone-containing medications.

Acetaminophen: The Non-Opioid Component

Acetaminophen (Tylenol) provides additional analgesic and antipyretic effects through inhibition of cyclooxygenase (COX) enzymes in the central nervous system. The acetaminophen component enhances oxycodone’s pain-relieving effects without contributing to opioid receptor activation.

The maximum safe daily dose of acetaminophen is 4,000 mg. Exceeding this threshold produces hepatotoxic damage to the liver, making acetaminophen accumulation a unique danger of Percocet misuse that does not apply to single-ingredient oxycodone products.

Available Dosage Strengths

Percocet is manufactured in several oxycodone/acetaminophen dose combinations. Standard Percocet formulations include:

• 2.5 mg/325 mg: The lowest-strength formulation, typically prescribed for mild to moderate pain.
• 5 mg/325 mg: The most commonly prescribed Percocet strength for moderate pain management.
• 7.5 mg/325 mg and 10 mg/325 mg: Higher-strength formulations reserved for more severe pain or patients with established opioid tolerance.

How the Body Metabolizes Percocet

The liver processes oxycodone through hepatic metabolism primarily mediated by cytochrome P450 enzymes CYP3A4 and CYP2D6.

Oxycodone Metabolism and Half-Life

CYP3A4 converts oxycodone into noroxycodone, an inactive metabolite that accounts for the majority of oxycodone clearance. CYP2D6 converts a smaller fraction into oxymorphone, an active metabolite with potent mu-opioid receptor binding affinity.

Oxycodone’s plasma elimination half-life averages approximately 3.2 hours in adults with normal liver and kidney function. Complete clearance from the bloodstream requires 4 to 5 half-lives, translating to approximately 16 to 20 hours after the last dose.

Acetaminophen Metabolism

Acetaminophen has a shorter half-life of approximately 2 to 3 hours and is metabolized primarily through glucuronidation and sulfation in the liver. A small fraction is converted by CYP2E1 into NAPQI, a toxic metabolite that causes hepatocellular necrosis when produced in excess.

At therapeutic doses, glutathione neutralizes NAPQI efficiently. At supratherapeutic doses (above 4,000 mg daily), glutathione reserves become depleted, allowing NAPQI to accumulate and produce potentially fatal liver damage.

Factors That Affect Percocet Detection Times

Several physiological and behavioral variables influence how long Percocet remains detectable. Key factors include:

• Dosage and frequency of use: Higher doses and chronic use patterns increase the total oxycodone and metabolite load in body tissues, extending detection windows beyond single-dose estimates.
• Liver function and CYP enzyme activity: Individuals with hepatic impairment or reduced CYP3A4/CYP2D6 activity metabolize oxycodone more slowly, prolonging elimination.
• Age and metabolic rate: Older adults process oxycodone approximately 15% more slowly than younger adults due to age-related declines in hepatic and renal clearance.
• Body composition: Oxycodone is moderately lipophilic, meaning individuals with higher body fat percentages may retain the drug slightly longer than lean individuals.
• Urinary pH: Acidic urine accelerates renal excretion of oxycodone metabolites, while alkaline urine promotes tubular reabsorption and slows clearance.
• Concurrent medications: CYP3A4 inhibitors (ketoconazole, erythromycin, grapefruit juice) slow oxycodone metabolism, while CYP3A4 inducers (rifampin, carbamazepine) accelerate clearance.

Percocet Detection Times by Test Type

Oxycodone detection windows vary considerably depending on which biological sample is tested and whether the assay specifically targets oxycodone.

Urine Testing for Percocet

Urine testing is the most common method for detecting oxycodone, but a critical limitation exists. Standard 5-panel and many 12-panel immunoassay screens test for morphine-derived opioids and frequently fail to detect oxycodone because it follows a different metabolic pathway.

Reliable Percocet detection requires an expanded opioid panel that specifically includes oxycodone and its metabolite oxymorphone. The SAMHSA workplace testing cutoff for oxycodone is 100 ng/mL on confirmatory GC-MS testing.

Oxycodone typically appears in urine within 1 to 3 hours after ingestion. For single-dose use, detection remains possible for 1 to 3 days. Chronic daily use may extend the detection window to 4 days as metabolites accumulate.

Blood Testing for Percocet

Blood tests detect oxycodone for approximately 15 to 24 hours after the last dose. Peak blood plasma concentration occurs 1 to 2 hours after oral ingestion of immediate-release Percocet.

Medical professionals primarily use blood testing in emergency departments to confirm acute opioid intoxication or to assess overdose severity. Blood testing provides the most accurate snapshot of current oxycodone levels but has the shortest detection window of any testing method.

Saliva Testing for Percocet

Saliva tests detect oxycodone for 1 to 4 days after the last dose. Oral fluid testing offers a non-invasive, observed collection method that reduces sample tampering risk compared to urine collection.

Oxycodone becomes detectable in saliva within 15 to 30 minutes of oral ingestion. Saliva testing is gaining adoption in workplace, roadside, and clinical settings as an alternative to urine-based screening.

Hair Follicle Testing for Percocet

Hair follicle analysis detects oxycodone use for up to 90 days. Drug metabolites deposit into the hair shaft through the bloodstream as the follicle grows, creating a chronological record of substance exposure.

Hair testing identifies patterns of repeated oxycodone use rather than single-dose events. The standard 1.5-inch hair sample represents approximately 90 days of growth from the scalp.

Side Effects and Risks of Percocet

Percocet produces opioid-mediated effects that range from common therapeutic side effects to life-threatening toxicity depending on dose and individual vulnerability.

Common Side Effects

Therapeutic doses of Percocet produce predictable mu-opioid receptor-mediated effects. Frequently reported side effects include:

• Drowsiness and sedation: Oxycodone suppresses cortical arousal pathways, producing dose-dependent sedation that impairs driving ability and cognitive function.
• Constipation: Mu-opioid receptors in the gastrointestinal tract slow intestinal motility, producing constipation that often persists throughout treatment and requires proactive management.
• Nausea and vomiting: Oxycodone stimulates the chemoreceptor trigger zone in the medulla, producing nausea that typically diminishes with continued use as tolerance develops.
• Dizziness and lightheadedness: Opioid-mediated vasodilation and blood pressure reduction produce orthostatic hypotension and vestibular instability.

Severe Side Effects and Overdose

Higher doses, polysubstance combinations, and opioid-naive exposure increase the risk of life-threatening Percocet toxicity. Severe effects requiring emergency medical attention include:

• Respiratory depression: Oxycodone suppresses brainstem respiratory drive in a dose-dependent manner. Combining Percocet with alcohol, benzodiazepines, or other CNS depressants dramatically amplifies this risk.
• Acetaminophen-induced hepatotoxicity: Percocet misuse frequently produces acetaminophen doses exceeding 4,000 mg daily, depleting hepatic glutathione and allowing NAPQI accumulation to cause acute liver failure.
• Loss of consciousness and coma: Excessive mu-opioid receptor stimulation produces profound CNS depression with loss of protective airway reflexes.
• Cardiac arrhythmia: QT prolongation and cardiac conduction abnormalities can occur at supratherapeutic oxycodone doses, particularly in individuals with pre-existing cardiac conditions.

Long-Term Effects of Percocet Use

Sustained Percocet use produces neuroadaptive changes that increase dependence severity and complicate discontinuation. Long-term consequences include:

• Opioid physical dependence: Chronic mu-opioid receptor activation produces neuroadaptive tolerance, requiring escalating doses to maintain the same analgesic effect and producing withdrawal upon cessation.
• Opioid-induced hyperalgesia: Paradoxically, chronic opioid exposure can increase pain sensitivity by upregulating pronociceptive pathways, making the original pain condition worse rather than better.
• Hormonal disruption: Long-term opioid use suppresses hypothalamic-pituitary-gonadal axis function, reducing testosterone and estrogen levels and producing fatigue, decreased libido, and osteoporosis risk.
• Cognitive impairment: Sustained opioid receptor activation impairs executive function, attention, and psychomotor processing speed.

Percocet Withdrawal Symptoms and Timeline

Percocet withdrawal produces a predictable opioid withdrawal syndrome driven by mu-opioid receptor vacancy and compensatory noradrenergic hyperactivity.

1. Hours 8 to 24 after last dose: Early withdrawal symptoms emerge as oxycodone blood levels drop. Anxiety, muscle aches, yawning, lacrimation, rhinorrhea, and restlessness signal the onset of withdrawal.
2. Days 1 to 3 (peak severity): Symptoms reach maximum intensity. Severe abdominal cramping, diarrhea, nausea, vomiting, piloerection, insomnia, dilated pupils, and intense drug cravings dominate this window.
3. Days 4 to 7 (gradual improvement): Acute physical symptoms begin subsiding. Gastrointestinal distress resolves, and vital signs stabilize. Psychological symptoms including anxiety, irritability, and cravings persist.
4. Weeks 2 to 4 and beyond (post-acute phase): Residual anxiety, insomnia, dysphoria, and episodic cravings gradually improve. Post-acute withdrawal syndrome (PAWS) may persist for weeks to months in individuals with chronic high-dose use histories.

Treatment for Opioid Use Disorder at Carolina Center for Recovery

Carolina Center for Recovery in Charlotte, North Carolina provides a full continuum of evidence-based care for individuals diagnosed with opioid use disorder involving Percocet or other oxycodone-containing medications.

Medical Detox Program

The medical detox unit provides 24/7 physician-supervised opioid withdrawal management within 16 private rooms. Clinical staff use individualized buprenorphine induction protocols and symptom management medications to minimize withdrawal severity and reduce cravings from the first day of admission.

Medication-Assisted Treatment (MAT)

Carolina Center for Recovery offers medication-assisted treatment with buprenorphine-based protocols that stabilize opioid receptor function, reduce cravings, and improve treatment retention throughout the recovery process.

Residential Treatment Program

The residential treatment program delivers 4 to 5 hours of daily structured programming including cognitive behavioral therapy, individual therapy, group counseling, and holistic modalities. Comprehensive psychiatric evaluation addresses co-occurring mood and anxiety disorders within the first 24 hours.

Partial Hospitalization and Outpatient Programs

The partial hospitalization program and intensive outpatient program provide step-down care as clients transition through the recovery continuum.

“Opioid dependence that started with a legitimate prescription is one of the most common pathways to our facility. At Carolina Center for Recovery, medication-assisted treatment is a core part of how we manage opioid withdrawal and long-term recovery. Our providers oversee MAT through every level of care, from detox through outpatient, and because many maintain private practices, clients can continue with the same doctor after discharge.”

— Sahil Talwar, PA-C, MBA, Medical Provider at Carolina Center for Recovery

Carolina Center for Recovery’s admissions team can verify insurance and schedule same-day assessments when capacity allows.

Frequently Asked Questions

How Long Will Percocet Stay in My Urine?

Oxycodone from Percocet remains detectable in urine for 1 to 3 days after a single dose and up to 4 days with chronic use. Standard opioid urine screens may not detect oxycodone because they target morphine-derived metabolites. A specific oxycodone immunoassay or expanded opioid panel is required for reliable urine detection.

How Long Do Opioids Stay Positive in Urine?

Detection times vary by specific opioid. Heroin and morphine are detectable for 2 to 3 days, oxycodone for 1 to 4 days, hydrocodone for 2 to 4 days, methadone for 7 to 10 days, and buprenorphine for 7 to 14 days. Chronic heavy use of any opioid extends the detection window beyond single-dose estimates due to metabolite tissue accumulation.

How Long Does Oxycodone Stay in a Person’s System?

Oxycodone has a plasma half-life of approximately 3.2 hours and clears from the bloodstream within 16 to 20 hours. However, metabolites remain detectable in urine for 1 to 4 days, in saliva for up to 4 days, and in hair for up to 90 days. Complete systemic elimination takes longer than blood clearance due to metabolite persistence in other tissues.

Can Percocet Show Up as Something Else on a Drug Test?

Percocet (oxycodone) does not typically produce false positives for other substances. However, oxycodone can trigger a positive result on certain broad-spectrum opioid immunoassays. Confirmatory GC-MS or LC-MS/MS testing definitively identifies oxycodone and distinguishes it from morphine, codeine, heroin metabolites, and other opioids.

How Long Do the Effects of Percocet Last?

A single dose of immediate-release Percocet produces analgesic effects lasting approximately 4 to 6 hours. Peak pain relief occurs 1 to 2 hours after oral ingestion. The euphoric effects sought through misuse typically last 3 to 5 hours before fading, which drives the compulsive redosing pattern that accelerates the development of opioid use disorder.

References

1. U.S. Food and Drug Administration. (2024). Percocet (oxycodone and acetaminophen) prescribing information. https://www.fda.gov
2. Drug Enforcement Administration. (2024). Drug fact sheet: Oxycodone. https://www.dea.gov/factsheets/oxycodone
3. Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2024
4. National Institute on Drug Abuse. (2024). Prescription opioids research report. https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs
5. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Association Publishing.
6. Kharasch, E. D. (2015). Oxycodone pharmacology and pharmacokinetics. Pain Medicine, 16(Suppl 1), S2-S10.